» Articles » PMID: 7017019

Selective Antimicrobial Modulation of Human Microbial Flora: Infection Prevention in Patients with Decreased Host Defense Mechanisms by Selective Elimination of Potentially Pathogenic Bacteria

Overview
Journal J Infect Dis
Date 1981 May 1
PMID 7017019
Citations 39
Authors
Affiliations
Soon will be listed here.
Abstract

To reduce the frequency and severity of bacterial infection, selective antimicrobial modulation (SAM) was applied in 39 patients with severely decreased host defense mechanisms. The objective was to eliminate potentially pathogenic aerobic microorganisms with minimal disturbance of the normal anaerobic bacterial flora. Elimination of potentially pathogenic aerobic microorganisms was easily accomplished in patients not infected at hospitalization. The anaerobic flora seemed to be undisturbed, and selection of or overgrowth with resistant microorganisms did not occur. The microbiologic results of the SAM regimen correlated with the incidence of infection. Only three major infections occurred in 23 patients who were free of potentially pathogenic microorganisms; 10 major infections occurred in 16 patients who were not free of potential pathogens. Seven of these 10 infections were present at hospitalization. The incidence of major infections was 47% in the patients on the SAM regimen and 82% in a group of control patients with a similar risk of infection.

Citing Articles

Antibiotic prophylaxis for bacterial infections in afebrile neutropenic patients following chemotherapy.

Gafter-Gvili A, Fraser A, Paul M, Vidal L, Lawrie T, van de Wetering M Cochrane Database Syst Rev. 2012; 1:CD004386.

PMID: 22258955 PMC: 4170789. DOI: 10.1002/14651858.CD004386.pub3.


Isolation and characterization of an attenuated strain of Pseudomonas aeruginosa AC869, a 3,5-dichlorobenzoate degrader.

Zhou X, George S, Frank D, Utley M, Gilmour I, Krogfelt K Appl Environ Microbiol. 1997; 63(4):1389-95.

PMID: 9097436 PMC: 168433. DOI: 10.1128/aem.63.4.1389-1395.1997.


Prophylactic use of the new quinolones for prevention of nosocomial infection in the intensive care unit.

Potgieter P, Hammond J Drugs. 1995; 49 Suppl 2:86-91.

PMID: 8549422 DOI: 10.2165/00003495-199500492-00014.


Oral enoxacin for infection prevention in adults with acute nonlymphocytic leukemia. The Enoxacin Prophylaxis Study Group.

Talbot G, Cassileth P, Paradiso L, Bond L Antimicrob Agents Chemother. 1993; 37(3):474-82.

PMID: 8460916 PMC: 187695. DOI: 10.1128/AAC.37.3.474.


Pulmonary clearance and inflammatory response in C3H/HeJ mice after intranasal exposure to Pseudomonas spp.

George S, Kohan M, Gilmour M, Taylor M, Brooks H, Creason J Appl Environ Microbiol. 1993; 59(11):3585-91.

PMID: 8285667 PMC: 182502. DOI: 10.1128/aem.59.11.3585-3591.1993.